ASX Press Release: February 19, 2017

ITL Half Year Results and BioMedical Growth Update

Following the strong first half results announced on Friday 17th February the company is issuing the following presentation – “Half year results 2016/17 and ITL BioMedical Growth Update” – in order to provide greater insight into ITL’s innovative products range and the exciting growth opportunities in the BioMedical division.

Click here to download the Full Presentation →

Read original article →

ITL BioMedical enables best clinical outcomes through innovative tools for blood management and clinical procedures. As a global provider of blood management and clinical procedure tools with a significant portfolio of intellectual property, we consistently look to the future and leverage input from healthcare markets worldwide to advance our products. Our world-class manufacturing facility and R&D lab develops and rigorously tests our advancements ensuring our innovations are designed with the utmost quality for introduction on a global basis.

ITL Half Year Results and BioMedical Growth Update

Essentials for Blood Management and Clinical Procedures

Product Catalogue